Skip to main content
Clinical Trials/KCT0003539
KCT0003539
Recruiting
未知

DEvelopment of Tools for Early diagnosis of operable Cancer with muTation enrichment plasma DNA sequencing and blood tumor marker

Kangbuk Samsung Medical Center0 sites840 target enrollmentTBD
ConditionsNeoplasms

Overview

Phase
未知
Intervention
Not specified
Conditions
Neoplasms
Sponsor
Kangbuk Samsung Medical Center
Enrollment
840
Status
Recruiting
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
7 years ago
Study Type
Observational Study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Histologically confirmed malignancy or strongly suspicious malignancy on PET\-CT / CT scanning
  • 2\. Patients scheduled for curative intended surgery and/or radiotherapy
  • 3\. No previous chemotherapy or radiotherapy before curative intended surgery
  • 4\. 20 years and older
  • 5\. Ability to provide written informed consent for blood sampling
  • 6\. Ability to understand the right to withdraw written informed consent without disadvantages

Exclusion Criteria

  • 1\. Previous history of chemotherapy and/or radiotherapy and/or curative intended surgery before study enrollment.
  • 2\. Previous history of malignancy within 3 years
  • 3\. History of organ transplantation requiring immunosuppressive treatment or peripheral blood stem cell transplantation

Outcomes

Primary Outcomes

Not specified

Similar Trials